Export

EN
FR
Methotrexate
Essential medicine status
General description

Recommendations
Section
Disease-modifying anti-rheumatic drugs (DMARDs)
  • Oral > Solid > tablet: 2.5 mg (as sodium salt)
Section
Medicines for juvenile joint diseases
  • Oral > Solid > tablet: 2.5 mg (as sodium salt)
Section
Dermatological medicines > Medicines affecting skin differentiation and proliferation
  • Oral > Solid > tablet: 2.5 mg (as sodium salt); 10 mg (as sodium salt)
Section
Immunomodulators for non-malignant disease
  • Parenteral > General injections > SC: pre-filled syringe in multiple strengths